CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 28.685

Change

-0.34 (-1.15)%

Market Cap

USD 0.28B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.55%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.13%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.09%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-0.38 (-0.27%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.07 (-0.13%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.81 (-0.83%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-5.36 (-0.95%)

USD 80.38B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 33.08% 96% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.08% 96% N/A 94% A
Trailing 12 Months  
Capital Gain 39.86% 94% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.86% 94% A 92% A
Trailing 5 Years  
Capital Gain 49.39% 74% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.39% 74% C 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 1.74% 34% F 36% F
Dividend Return 1.98% 35% F 36% F
Total Return 0.24% 22% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 17.43% 26% F 39% F
Risk Adjusted Return 11.38% 29% F 31% F
Market Capitalization 0.28B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.